the evolving treatment landscape in pv
Published 2 weeks ago • 52 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
0:53
evolution of the treatment landscape for patients with cns lymphoma
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
4:04
developments within the gvhd treatment landscape
-
2:21
the role of melflufen in the myeloma treatment landscape
-
2:44
myelofibrosis: jenson shares his experience
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
21:38
drawing the line: the rationale behind blood tube collection order
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
1:54
current treatment landscape in classical mpns
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:03
the current landscape of treatment for bpdcn
-
2:18
the current landscape of treatment for bpdcn
-
0:56
the role of navtemadlin in the mpn treatment landscape
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:36
the current treatment landscape for aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies